Back to Search
Start Over
Recurrent anaphylaxis to a gelatin-based colloid plasma substitute and to cetuximab following sensitisation to galactose-alpha-1,3-galactose.
- Source :
-
British journal of anaesthesia [Br J Anaesth] 2021 Jun; Vol. 126 (6), pp. e200-e202. Date of Electronic Publication: 2021 Mar 31. - Publication Year :
- 2021
-
Abstract
- Competing Interests: Declarations of interest The authors declare that they have no conflicts of interest.
- Subjects :
- Adult
Anaphylaxis blood
Anaphylaxis diagnosis
Anaphylaxis immunology
Biomarkers blood
Drug Hypersensitivity blood
Drug Hypersensitivity diagnosis
Drug Hypersensitivity immunology
Epitopes
Humans
Male
Risk Factors
Anaphylaxis chemically induced
Antineoplastic Agents, Immunological adverse effects
Cetuximab adverse effects
Disaccharides immunology
Drug Hypersensitivity etiology
Immunoglobulin E blood
Plasma Substitutes adverse effects
Polygeline adverse effects
Subjects
Details
- Language :
- English
- ISSN :
- 1471-6771
- Volume :
- 126
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- British journal of anaesthesia
- Publication Type :
- Report
- Accession number :
- 33810867
- Full Text :
- https://doi.org/10.1016/j.bja.2021.02.013